Olga N. Kurochkina
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Olga N. Kurochkina has a total of 47 co-authors. Here are the top co-authors by number of shared publications:
- Андрей Николаевич Богомолов
Alexandrovskaya Hospital; St. Petersburg Institute of Bioregulation and Gerontology
13 shared publications - Dmitrii A. Korotkov
Pitirim Sorokin Syktyvkar State University
5 shared publications - Anastasiya S. Sazhina
Pitirim Sorokin Syktyvkar State University
4 shared publications - Kirill L. Kozlov
S.M. Kirov Military Medical Academy
4 shared publications - Aleksandr V. Baranov
Pitirim Sorokin Syktyvkar State University; Northern State Medical University
3 shared publications - Aleksandr Leonidovich Khokhlov
Yaroslavl State Medical University
2 shared publications
Latest Publications
- Open Access
- 13 August 2026
- Published by Silicea - Poligraf, LLC in Russian Journal of Cardiology
- Vol. 31 (8S) , 7086
Severe toxic cardiomyopathy in a young patient: a case report
Introduction . The consumption of energy drinks (EDs) in combination with alcohol and nicotine products (vaping) is reaching epidemic proportions among young people. This dangerous combination has a pronounced cardiotoxic effect, triggering arrhythmias and heart failure (HF). The aim of this article was to present a clinical case of severe cardiomyopathy in a young patient secondary to the toxic effects of EDs, alcohol, and nicotine. Brief description. A 22-year-old patient was hospitalized with progressive shortness of breath, weakness, and atrial fibrillation with a rapid ventricular rhythm (heart rate up to 150 bpm). There was a regular excessive consumption of energy drinks, alcohol, and vaping. Upon admission, biventricular heart failure with a left ventricular ejection fraction of 20%, cardiogenic shock, and multiple organ failure were detected. Coronary angiography revealed no coronary artery disease. Cardiac magnetic resonance imaging revealed diffuse hypokinesia without signs of fibrosis. Significant improvement was observed with intensive care, hemodialysis, and restoration of sinus rhythm by electrical cardioversion. Discussion . This case shows the potential for reversibility of severe myocardial dysfunction in young individuals with timely diagnosis of tachycardiomyopathy and toxic damage.
- 13 August 2026
- Published by Silicea - Poligraf, LLC in Russian Journal of Cardiology
- Vol. 31 (8S) , 7086
Open AccessSevere toxic cardiomyopathy in a young patient: a case report
Introduction . The consumption of energy drinks (EDs) in combination with alcohol and nicotine products (vaping) is reaching epidemic proportions among young people. This dangerous combination has a pronounced cardiotoxic effect, triggering arrhythmias and heart failure (HF). The aim of this article was to present a clinical case of severe cardiomyopathy in a young patient secondary to the toxic effects of EDs, alcohol, and nicotine. Brief description. A 22-year-old patient was hospitalized with progressive shortness of breath, weakness, and atrial fibrillation with a rapid ventricular rhythm (heart rate up to 150 bpm). There was a regular excessive consumption of energy drinks, alcohol, and vaping. Upon admission, biventricular heart failure with a left ventricular ejection fraction of 20%, cardiogenic shock, and multiple organ failure were detected. Coronary angiography revealed no coronary artery disease. Cardiac magnetic resonance imaging revealed diffuse hypokinesia without signs of fibrosis. Significant improvement was observed with intensive care, hemodialysis, and restoration of sinus rhythm by electrical cardioversion. Discussion . This case shows the potential for reversibility of severe myocardial dysfunction in young individuals with timely diagnosis of tachycardiomyopathy and toxic damage.
- 22 April 2026
- Published by Silicea - Poligraf, LLC in Russian Journal of Cardiology
- Vol. 31 (2S)
Siponimod in acute ischemic stroke: rationale for the selective sphingosine-1-phosphate receptor modulator repurposing hypothesis with a focus on cardiovascular safety. A review
Acute ischemic stroke remains a cause of high mortality and disability. Existing treatments are limited by a small therapeutic window. Fingolimod has demonstrated neuroprotective potential, but its use is limited by cardiovascular risks (bradycardia) due to S1PR3 activation. Siponimod is a selective S1PR1/S1PR5 modulator without activity on S1PR3. Analysis of the mechanisms of action, clinical data, and pharmacoeconomic modeling indicate that siponimod may be more effective and safer than fingolimod in ischemic stroke. Artificial intelligence modeling of a clinical trial shows that the use of siponimod in 1000 patients could prevent disability in 510 people and save over RUB1,6 billion. The ICER is 11765 RUB/QALY. Thus, siponimod is a promising candidate for repurposing with a favorable cardiac profile.
- 22 April 2026
- Published by Silicea - Poligraf, LLC in Russian Journal of Cardiology
- Vol. 31 (2S)
Siponimod in acute ischemic stroke: rationale for the selective sphingosine-1-phosphate receptor modulator repurposing hypothesis with a focus on cardiovascular safety. A review
Acute ischemic stroke remains a cause of high mortality and disability. Existing treatments are limited by a small therapeutic window. Fingolimod has demonstrated neuroprotective potential, but its use is limited by cardiovascular risks (bradycardia) due to S1PR3 activation. Siponimod is a selective S1PR1/S1PR5 modulator without activity on S1PR3. Analysis of the mechanisms of action, clinical data, and pharmacoeconomic modeling indicate that siponimod may be more effective and safer than fingolimod in ischemic stroke. Artificial intelligence modeling of a clinical trial shows that the use of siponimod in 1000 patients could prevent disability in 510 people and save over RUB1,6 billion. The ICER is 11765 RUB/QALY. Thus, siponimod is a promising candidate for repurposing with a favorable cardiac profile.
- 22 April 2026
- Published by Silicea - Poligraf, LLC in Russian Journal of Cardiology
- Vol. 31 (2S)
Ensemble machine learning predictors: a novel approach to assessing the risk of inhospital mortality in patients with acute coronary syndrome
Aim . To evaluate the effectiveness of modern ensemble machine learning (ML) models in predicting in-hospital mortality in patients with acute coronary syndrome (ACS) compared to the traditional GRACE clinical score. Material and methods. This retrospective study included anonymized data from 14420 patients with ACS admitted to a cardiology hospital. For each case, 28 predictors were analyzed. Following machine learning algorithms were trained using this data: logistic regression, decision trees, random forest, and gradient boosting (XGBoost, CatBoost). The area under the receiver operating characteristic (AUC-ROC), recall, and F1 score were used to assess the model quality. The results of the best model were compared with the GRACE risk score. SHAP analysis was used to interpret the algorithm logic. R e sults . Inhospital mortality was 6,03% (n=804). Gradient boosting algorithms demonstrated the highest predictive capability. The CatBoost model emerged as the top performer, achieving an AUC-ROC of 0,961, significantly outperforming the GRACE score (AUC-ROC 0,919) on the test set. SHAP analysis revealed that the greatest contributors to the model’s prediction were history of dyslipidemia, left ventricular ejection fraction, Killip class of acute heart failure, age, and systolic blood pressure levels. The model successfully identified hidden nonlinear clinical patterns, including the paradoxical protective effect of previously diagnosed dyslipidemia and the critical prognostic significance of missing medical history data upon admission. Conclusion . ML methods, particularly the CatBoost algorithm, provide higher accuracy in predicting in-hospital mortality in ACS compared to conventional scores. The ability of these algorithms to account for complex nonlinear relationships between clinical indicators makes them a promising foundation for developing accurate clinical decision support systems.
- 22 April 2026
- Published by Silicea - Poligraf, LLC in Russian Journal of Cardiology
- Vol. 31 (2S)
Ensemble machine learning predictors: a novel approach to assessing the risk of inhospital mortality in patients with acute coronary syndrome
Aim . To evaluate the effectiveness of modern ensemble machine learning (ML) models in predicting in-hospital mortality in patients with acute coronary syndrome (ACS) compared to the traditional GRACE clinical score. Material and methods. This retrospective study included anonymized data from 14420 patients with ACS admitted to a cardiology hospital. For each case, 28 predictors were analyzed. Following machine learning algorithms were trained using this data: logistic regression, decision trees, random forest, and gradient boosting (XGBoost, CatBoost). The area under the receiver operating characteristic (AUC-ROC), recall, and F1 score were used to assess the model quality. The results of the best model were compared with the GRACE risk score. SHAP analysis was used to interpret the algorithm logic. R e sults . Inhospital mortality was 6,03% (n=804). Gradient boosting algorithms demonstrated the highest predictive capability. The CatBoost model emerged as the top performer, achieving an AUC-ROC of 0,961, significantly outperforming the GRACE score (AUC-ROC 0,919) on the test set. SHAP analysis revealed that the greatest contributors to the model’s prediction were history of dyslipidemia, left ventricular ejection fraction, Killip class of acute heart failure, age, and systolic blood pressure levels. The model successfully identified hidden nonlinear clinical patterns, including the paradoxical protective effect of previously diagnosed dyslipidemia and the critical prognostic significance of missing medical history data upon admission. Conclusion . ML methods, particularly the CatBoost algorithm, provide higher accuracy in predicting in-hospital mortality in ACS compared to conventional scores. The ability of these algorithms to account for complex nonlinear relationships between clinical indicators makes them a promising foundation for developing accurate clinical decision support systems.
- 2 April 2026
- Published by Media Sphere Publishing Group in Russian Cardiology Bulletin
- Vol. 21 (1)
Clinical characteristics of patients with acute coronary syndrome according to the regional vascular center registry
Objective. To analyze clinical characteristics of patients with acute coronary syndrome according to the regional vascular center registry and to compare these results with other registries. Material and methods. The ACS register included all patients hospitalized in the regional vascular center of the Alexandrovskaya Hospital with ACS or myocardial infarction (MI). We analyzed 14412 cases of hospitalization for the period from 06.02.2016 to 22.11.2024, including 12.869 people with correctly completed data. Men comprised 58.5%. Results. Among all patients, 78.3% were admitted on the referral of emergency medical care, 12.6% — on the referral of the polyclinic, 6.8% came by self-referral, 2.3% were transferred from other hospitals; 97.7% of patients with ACS were hospitalized directly in the regional vascular center. Symptoms of ACS included weakness in 58.7% of patients, chest pain in 28.3%, shortness of breath in 9.1%; 7.8% were asymptomatic. Patients with ACS received adequate drug therapy in accordance with current clinical guidelines; the incidence of percutaneous coronary interventions was higher than mean value for the Russian Federation. Acute heart failure (p<0.0001), cardiogenic shock (p<0.0001), and death were more common in patients with ST-segment elevation. Conclusion. Hospitalization of 97.7% of patients with ACS directly in the regional vascular center indicates optimal organization of medical care for these patients. Emergency care for patients with ACS is carried out at a high level. MI may be atypical without pain syndrome that should be taken into account when making a diagnosis. More severe status of patients with STEMI dictates the need for early perfusion therapy.
- 2 April 2026
- Published by Media Sphere Publishing Group in Russian Cardiology Bulletin
- Vol. 21 (1)
Clinical characteristics of patients with acute coronary syndrome according to the regional vascular center registry
Objective. To analyze clinical characteristics of patients with acute coronary syndrome according to the regional vascular center registry and to compare these results with other registries. Material and methods. The ACS register included all patients hospitalized in the regional vascular center of the Alexandrovskaya Hospital with ACS or myocardial infarction (MI). We analyzed 14412 cases of hospitalization for the period from 06.02.2016 to 22.11.2024, including 12.869 people with correctly completed data. Men comprised 58.5%. Results. Among all patients, 78.3% were admitted on the referral of emergency medical care, 12.6% — on the referral of the polyclinic, 6.8% came by self-referral, 2.3% were transferred from other hospitals; 97.7% of patients with ACS were hospitalized directly in the regional vascular center. Symptoms of ACS included weakness in 58.7% of patients, chest pain in 28.3%, shortness of breath in 9.1%; 7.8% were asymptomatic. Patients with ACS received adequate drug therapy in accordance with current clinical guidelines; the incidence of percutaneous coronary interventions was higher than mean value for the Russian Federation. Acute heart failure (p<0.0001), cardiogenic shock (p<0.0001), and death were more common in patients with ST-segment elevation. Conclusion. Hospitalization of 97.7% of patients with ACS directly in the regional vascular center indicates optimal organization of medical care for these patients. Emergency care for patients with ACS is carried out at a high level. MI may be atypical without pain syndrome that should be taken into account when making a diagnosis. More severe status of patients with STEMI dictates the need for early perfusion therapy.
- Open Access
- 18 January 2026
- Published by Silicea - Poligraf, LLC in Russian Journal of Cardiology
- Vol. 30 (12) , 6268
Initial results of the heart failure center implementation at a level 3 cardiology facility
Aim . To study the results of the heart failure center (HFC) implementation at a level 3 cardiology facility and to assess the rehospitalization risks and the economic impact of HFCs in real-world clinical practice. M aterial and methods . The study included 414 patients undergoing inpatient treatment at a level 3 facility. The primary inclusion criterion was the echocardiographic detection of reduced and mildly reduced ejection fraction. Patients were divided into two following groups: group 1 (n=154) — patients who continued outpatient follow-up in the HF office after discharge; group 2 (n=222) — those who were not followed in the HF office. An analysis of patient readmissions was conducted using data from a unified digital platform. Statistical data processing was performed using Excel and Biostat, with Student’s t-test and chi-square tests. The cost-effectiveness of the HF office was calculated. R esults. A HF office was established at a level 3 facility, comprising inpatient and outpatient follow-up phases using a seamless model. In both groups, there were more men than women. Patients were comparable in age, clinical status, and comorbidities. The main causes of HF in the study groups were coronary artery disease, including prior myocardial infarction, and atrial fibrillation. Upon discharge from the hospital, all patients were recommended quadruple therapy for HF. Patients in the first group visited the HF office 362 times over the course of a year. An analysis of readmissions was conducted over a one-year follow-up period after discharge. The proportion of patients readmitted to the hospital within a year of discharge was significantly higher in group 2 (37,5%) than in group 1 (13,6%) (odds ratio 3,782; 95% confidence interval 2,216-6,454; pConclusion . Monitoring in the HF office significantly reduces readmissions and alleviates the burden on the healthcare system.
- 18 January 2026
- Published by Silicea - Poligraf, LLC in Russian Journal of Cardiology
- Vol. 30 (12) , 6268
Open AccessInitial results of the heart failure center implementation at a level 3 cardiology facility
Aim . To study the results of the heart failure center (HFC) implementation at a level 3 cardiology facility and to assess the rehospitalization risks and the economic impact of HFCs in real-world clinical practice. M aterial and methods . The study included 414 patients undergoing inpatient treatment at a level 3 facility. The primary inclusion criterion was the echocardiographic detection of reduced and mildly reduced ejection fraction. Patients were divided into two following groups: group 1 (n=154) — patients who continued outpatient follow-up in the HF office after discharge; group 2 (n=222) — those who were not followed in the HF office. An analysis of patient readmissions was conducted using data from a unified digital platform. Statistical data processing was performed using Excel and Biostat, with Student’s t-test and chi-square tests. The cost-effectiveness of the HF office was calculated. R esults. A HF office was established at a level 3 facility, comprising inpatient and outpatient follow-up phases using a seamless model. In both groups, there were more men than women. Patients were comparable in age, clinical status, and comorbidities. The main causes of HF in the study groups were coronary artery disease, including prior myocardial infarction, and atrial fibrillation. Upon discharge from the hospital, all patients were recommended quadruple therapy for HF. Patients in the first group visited the HF office 362 times over the course of a year. An analysis of readmissions was conducted over a one-year follow-up period after discharge. The proportion of patients readmitted to the hospital within a year of discharge was significantly higher in group 2 (37,5%) than in group 1 (13,6%) (odds ratio 3,782; 95% confidence interval 2,216-6,454; pConclusion . Monitoring in the HF office significantly reduces readmissions and alleviates the burden on the healthcare system.
- 1 January 2026
- Published by Geotar-Media Publishing Group in Cardiology: News, Opinions, Training
- Vol. 14 (2)
Features of the course of acute myocardial infarction with ST segment elevation
- 1 January 2026
- Published by Geotar-Media Publishing Group in Cardiology: News, Opinions, Training
- Vol. 14 (2)
Features of the course of acute myocardial infarction with ST segment elevation
- 19 December 2025
- Published by Bionika Media in Pharmateca
- Vol. 8_2025
Gender-related patterns of comorbidity in patients with chronic heart failure
- 19 December 2025
- Published by Bionika Media in Pharmateca
- Vol. 8_2025
Gender-related patterns of comorbidity in patients with chronic heart failure
- 14 December 2025
- Published by Autonomous non-profit organization-Society of Specialists in the Field Innovative Medical Technology in Russian Journal of Geriatric Medicine
- No. 4
Atherosclerotic cardiovascular disease and type 2 diabetes mellitus in elderly patients: risk management (review)
Atherosclerotic cardiovascular diseases (ASCVD) account for nearly half of all deaths in the Russian Federation. In a considerable number of cases, elderly patients have concomitant ASCVD and type 2 diabetes mellitus (T2DM), with ASCVD being the primary cause of death in patients with T2DM. The presence of shared risk factors and the presence of close pathophysiological relationships among these diseases suggests the potential for therapeutic action on both T2DM and ASCVD simultaneously. The therapeutic approach for type 2 diabetes mellitus (T2DM) in elderly patients with atherosclerotic cardiovascular disease (ASCVD) is a complex task due to changes in the functional and psychosocial status of patients, comorbidities, and polypharmacy. Therefore, the selection of therapeutic interventions for these patients requires an individualized approach. Presently, the selection of hypoglycemic medications is informed by their impact on cardiovascular outcomes and the safety profile with respect to hypoglycemia, a consideration of particular significance for elderly and senile patients. The review methodically analyzes current literature data on drugs for the treatment of elderly patients with ASCVD and T2DM, providing a concise overview of the mechanisms of action and the evidence base for their efficacy and safety. The objective of this information is to facilitate treatment decisions for patients with T2DM and ASCVD, including elderly and geriatric patients, within the context of routine clinical practice.
- 14 December 2025
- Published by Autonomous non-profit organization-Society of Specialists in the Field Innovative Medical Technology in Russian Journal of Geriatric Medicine
- No. 4
Atherosclerotic cardiovascular disease and type 2 diabetes mellitus in elderly patients: risk management (review)
Atherosclerotic cardiovascular diseases (ASCVD) account for nearly half of all deaths in the Russian Federation. In a considerable number of cases, elderly patients have concomitant ASCVD and type 2 diabetes mellitus (T2DM), with ASCVD being the primary cause of death in patients with T2DM. The presence of shared risk factors and the presence of close pathophysiological relationships among these diseases suggests the potential for therapeutic action on both T2DM and ASCVD simultaneously. The therapeutic approach for type 2 diabetes mellitus (T2DM) in elderly patients with atherosclerotic cardiovascular disease (ASCVD) is a complex task due to changes in the functional and psychosocial status of patients, comorbidities, and polypharmacy. Therefore, the selection of therapeutic interventions for these patients requires an individualized approach. Presently, the selection of hypoglycemic medications is informed by their impact on cardiovascular outcomes and the safety profile with respect to hypoglycemia, a consideration of particular significance for elderly and senile patients. The review methodically analyzes current literature data on drugs for the treatment of elderly patients with ASCVD and T2DM, providing a concise overview of the mechanisms of action and the evidence base for their efficacy and safety. The objective of this information is to facilitate treatment decisions for patients with T2DM and ASCVD, including elderly and geriatric patients, within the context of routine clinical practice.
- Open Access
- 28 February 2025
- Published by NII KPSSZ in Complex Issues of Cardiovascular Diseases
- Vol. 14 (1) , 232-240
COMPREHENSIVE ASSESSMENT OF THE ROLE OF NUTRITION AND INTESTINAL MICROFLORA IN THE DEVELOPMENT OF ATHEROSCLEROTIC CARDIOVASCULAR DISEASES (LITERATURE REVIEW)
HighlightsConsumption of high-calorie Western-type foods in combination with overeating and a sedentary lifestyle causes a violation of the composition of the intestinal microbiota, increased intestinal permeability, increased intake of lipopolysaccharide, trimethylamine-N-oxide and other toxins into the blood, which causes a state of chronic metabolic inflammation followed by accelerated development of ASD. Adherence to the Mediterranean diet normalizes the composition of the intestinal microbiota, promotes the formation of short-chain fatty acids with anti-inflammatory and anti-atherosclerotic effects. AbsractDespite the introduction of new treatment methods, atherosclerotic cardiovascular diseases (ASCVD) remain the leading cause of morbidity and mortality worldwide. In recent years, it has been established that systemic inflammation plays a crucial role in atherothrombosis, but the factors causing systemic inflammation have not been fully elucidated. The consumption of high-calorie Western-type foods combined with chronic overeating and a sedentary lifestyle in Western societies causes a state of chronic metabolic inflammation, which contributes to the development of ASCVD. A better understanding of how different types of nutrition affect the pathogenesis of atherosclerosis is essential for developing effective strategies for the prevention and treatment of ASCVD. This article reviews the latest data on the pathogenetic mechanisms of the influence of dietary patterns on the development or regression of ASCVD.
- 28 February 2025
- Published by NII KPSSZ in Complex Issues of Cardiovascular Diseases
- Vol. 14 (1) , 232-240
Open AccessCOMPREHENSIVE ASSESSMENT OF THE ROLE OF NUTRITION AND INTESTINAL MICROFLORA IN THE DEVELOPMENT OF ATHEROSCLEROTIC CARDIOVASCULAR DISEASES (LITERATURE REVIEW)
HighlightsConsumption of high-calorie Western-type foods in combination with overeating and a sedentary lifestyle causes a violation of the composition of the intestinal microbiota, increased intestinal permeability, increased intake of lipopolysaccharide, trimethylamine-N-oxide and other toxins into the blood, which causes a state of chronic metabolic inflammation followed by accelerated development of ASD. Adherence to the Mediterranean diet normalizes the composition of the intestinal microbiota, promotes the formation of short-chain fatty acids with anti-inflammatory and anti-atherosclerotic effects. AbsractDespite the introduction of new treatment methods, atherosclerotic cardiovascular diseases (ASCVD) remain the leading cause of morbidity and mortality worldwide. In recent years, it has been established that systemic inflammation plays a crucial role in atherothrombosis, but the factors causing systemic inflammation have not been fully elucidated. The consumption of high-calorie Western-type foods combined with chronic overeating and a sedentary lifestyle in Western societies causes a state of chronic metabolic inflammation, which contributes to the development of ASCVD. A better understanding of how different types of nutrition affect the pathogenesis of atherosclerosis is essential for developing effective strategies for the prevention and treatment of ASCVD. This article reviews the latest data on the pathogenetic mechanisms of the influence of dietary patterns on the development or regression of ASCVD.
- Open Access
- 17 September 2024
- Published by FSBEI of Higher Education SamSMU of Ministry of Health of the Russian Federation in Science and Innovations in Medicine
- Vol. 9 (3) , 197-202
Long-term risk predictors of adverse events in patients with chronic heart failure
Aim – to identify predictors of the risk of adverse events over a three-year period in patients with chronic heart failure (CHF). Material and methods. A retrospective study was conducted on 278 people diagnosed with CHF in patients with coronary heart disease (CHD). A sample of data was made, survival assessment, Charson comorbidity index was calculated. Statistical data processing was carried out using Excel and XLSTAT programs with linear regression calculations. Results. A statistically significant direct relationship between three-year survival was identified with the following indicators: age over 66 years, stage IIB-III CHF, Echo-CG data (low LVEF, left ventricular diameter, systolic pressure in the pulmonary artery (SPAP), the presence of hypertension (HBP) and atrial fibrillation (AF), Charlson comorbidity index of more than 5 points, glomerular filtration rate (GFR) less than 60 ml/min, complete blood count (CBC) data - a decrease in hemoglobin level below 131 g/l and an increase in ESR level above 14 mm/h. Surgical interventions such as coronary artery bypass grafting (CABG) and percutaneous coronary intervention (PCI) were associated with better patient survival. Conclusion. In order to ensure qualified monitoring of patients with CHF and ensure continuity of management of these patients, it seems relevant to create a specialized office for the management of patients with CHF.
- 17 September 2024
- Published by FSBEI of Higher Education SamSMU of Ministry of Health of the Russian Federation in Science and Innovations in Medicine
- Vol. 9 (3) , 197-202
Open AccessLong-term risk predictors of adverse events in patients with chronic heart failure
Aim – to identify predictors of the risk of adverse events over a three-year period in patients with chronic heart failure (CHF). Material and methods. A retrospective study was conducted on 278 people diagnosed with CHF in patients with coronary heart disease (CHD). A sample of data was made, survival assessment, Charson comorbidity index was calculated. Statistical data processing was carried out using Excel and XLSTAT programs with linear regression calculations. Results. A statistically significant direct relationship between three-year survival was identified with the following indicators: age over 66 years, stage IIB-III CHF, Echo-CG data (low LVEF, left ventricular diameter, systolic pressure in the pulmonary artery (SPAP), the presence of hypertension (HBP) and atrial fibrillation (AF), Charlson comorbidity index of more than 5 points, glomerular filtration rate (GFR) less than 60 ml/min, complete blood count (CBC) data - a decrease in hemoglobin level below 131 g/l and an increase in ESR level above 14 mm/h. Surgical interventions such as coronary artery bypass grafting (CABG) and percutaneous coronary intervention (PCI) were associated with better patient survival. Conclusion. In order to ensure qualified monitoring of patients with CHF and ensure continuity of management of these patients, it seems relevant to create a specialized office for the management of patients with CHF.